LightPath Technologies, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2012 (not calendar-year 2011 Q4). The company manufactures optical components and assemblies, with operations in Orlando and Shanghai. Its products include molded optics, infrared optics, isolators, collimators and GRADIUM lenses.
Key financial results
| Metric | FY2012 | FY2011 |
|---|---|---|
| Revenue | $11.285 million | $10.001 million |
| Gross margin | $4.035 million; 35.7% | $3.922 million; 39.2% |
| Operating loss | $924,000 | $857,000 |
| Net loss | $865,000; $0.09 per share | $1.602 million; $0.17 per share |
| Cash from operations | $406,000 | $95,000 |
| Capital expenditures | $629,000 | $908,000 |
- Revenue rose 13%, driven by a Raytheon order, precision molded lenses for telecom and laser-tool markets, and custom optics. Units of precision molded optics sold increased 13%.
- Gross margin dollars increased only about $110,000 as manufacturing costs rose $1.17 million; gross margin percentage declined three percentage points.
- Net loss narrowed by approximately $737,000, principally due to lower debt-related interest expense and higher revenue. The operating loss nevertheless increased.
- Cash and cash equivalents were $2.354 million at June 30, 2012, versus $929,000 a year earlier. Current assets were $6.250 million and current liabilities $1.741 million.
- Total liabilities were $4.269 million. The company had $1.088 million of 8% convertible debentures outstanding, due August 1, 2013, and a $1.087 million warrant liability. Debentures are secured by substantially all previously unencumbered assets and guaranteed by subsidiaries.
- Inventory declined to $1.513 million from $1.623 million; average days cost of sales in inventory fell to 76 from 90. Average days sales outstanding increased to 68 from 63.
Changes, financing and outlook
- In June 2012, the company sold 1,943,852 shares at $1.02 per share, raising about $1.983 million gross and $1.597 million net, and issued warrants to buy additional shares. The offering increased the share count and the warrants may create further dilution.
- Management reported recurring operating losses and an accumulated deficit of $204.6 million. It said available resources were adequate for the fiscal 2013 plan and current operations for the coming year, but acknowledged that further financing may be needed if sales growth and cost improvements fall short.
- Management expected modest revenue growth in fiscal 2013, led by precision molded optics, low-cost/high-volume Asian applications, infrared products and collimators. It anticipated margin improvement from production efficiencies and lower product costs, while also expecting some increases in selling, administrative and development expenses.
- Planned fiscal 2013 new-product development spending was approximately $1.29 million. Capital spending was expected to increase, though the filing gives no specific forecast amount. The company had approximately $4.892 million of 12-month backlog at June 30, 2012.
- A $1.1 million Raytheon Vision Systems development order supports a defense thermal-imaging program; completion was expected by July 2013. Revenue is recognized using a cost-to-cost percentage-of-completion method.
- The company withdrew a planned public offering in January 2012 due to business, economic and market conditions and wrote off approximately $227,000 of prepaid offering costs.
Risks, contingencies and other notable items
- Liquidity remains sensitive to sales growth, gross-margin gains, material and labor costs, and execution of planned production efficiencies. Management warned that unavailable or unfavorable financing could require additional cost actions or consideration of strategic alternatives.
- Four customers accounted for at least 5% of fiscal 2012 revenue: Crimson Trace 10%, Thorlabs 9%, AMS Technologies 9% and Raytheon Missile Systems 5%. The filing warns that losing a significant customer could adversely affect revenue.
- Approximately 31% of revenue came from outside the United States. Some key materials have limited suppliers, and management could not assure continued supply at competitive prices.
- The June 2012 warrants are accounted for as a Level 3 liability and remeasured each reporting period; the fiscal-year fair-value change produced a $103,000 gain. Their valuation depends on model assumptions.
- Management said ordinary-course legal matters were not expected to have a material adverse effect. Disclosure controls and internal control over financial reporting were assessed as effective; the auditor did not attest to internal-control effectiveness.
- No cash dividends have been paid, and debenture terms prohibit dividends while the debt remains outstanding. Management reported no profitability in fiscal 2012 or 2011.
Investor verification priorities
- Review cash use, current liquidity and whether operating cash flow can remain positive without additional financing.
- Verify the August 1, 2013 debenture maturity, repayment or conversion plans, security interests and related-party holdings.
- Assess dilution from the June 2012 share issuance and outstanding warrants, including the accounting and valuation of the warrant liability.
- Track backlog conversion, customer concentration and progress and cash collection on the Raytheon development order.
- Compare fiscal 2013 sales, margin, development and capital-spending plans with actual results; test the assumptions underlying management’s one-year liquidity assessment.